2024

1. Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network

   Arthritis and Rheumatology, Vol. 76, Núm. 4, pp. 587-598